Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
08/2003
08/28/2003WO2003070967A2 Highly homogeneous molecular markers for electrophoresis
08/28/2003WO2003070965A2 The eaat2 promoter and uses thereof
08/28/2003WO2003070963A2 Improved protein expression in bacillus subtilis
08/28/2003WO2003070961A1 Chimeric cannulae proteins, nucleic acids encoding them and methods for making and using them
08/28/2003WO2003070954A1 Transcriptional factor, transcriptional factor gene, recombinant vector containing transcriptional factor gene, koji-mold transformed by the vector and method of using koji-mold
08/28/2003WO2003070953A1 Novel compound for inhibiting serine proteases and for inhibiting viral infections or viral propagation: rld 8564
08/28/2003WO2003070952A1 Fluorescent protein
08/28/2003WO2003070950A1 Novel dna and use thereof
08/28/2003WO2003070949A1 Cat immunisation vectors
08/28/2003WO2003070946A1 Molecules associating to c-terminal domain in receptor cell
08/28/2003WO2003070941A2 Method for the identification of tissue-specific regulatory sequences
08/28/2003WO2003070937A1 Protein having osteogenic protein-binding region and gene encoding the same
08/28/2003WO2003070936A1 Novel polypeptide
08/28/2003WO2003070934A1 METHOD OF JUDGING GENOTYPE OF REGION AROUND PLANT sd-1 GENE AND METHOD OF EXAMINING SEMI-DWARF CHARACTERISTIC OF PLANT USING THE JUDGMENT METHOD
08/28/2003WO2003070927A1 Regulation of human gtpase
08/28/2003WO2003070919A1 Antimicrobial composition
08/28/2003WO2003070916A2 Dna encoding snorf44 receptor
08/28/2003WO2003070915A2 Mutated constitutively active nuclear orphan receptor
08/28/2003WO2003070906A2 Cellular genes regulated by hiv-1 infection and methods of use thereof
08/28/2003WO2003070900A2 Cftr with a partially deleted r domain and uses thereof
08/28/2003WO2003070893A2 Wip, a wasp-associated protein
08/28/2003WO2003070892A2 Inhibitors of rgs proteins
08/28/2003WO2003070890A2 THE p65 SUBUNIT OF NF-κB FOR THE RADIOSENSITIZATION OF CELLS
08/28/2003WO2003070882A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and used thereof
08/28/2003WO2003070879A2 Cyclin dependent kinase 5 phosphorylation of disabled 1 protein
08/28/2003WO2003070771A1 Rrp sequences and knockout mice and uses thereof
08/28/2003WO2003070770A2 Engineered human kunitz-type protease inhibitor
08/28/2003WO2003070769A2 Organic compounds having anti-angiogenic activity
08/28/2003WO2003070768A2 Cd40 splice variants,method of detection thereof, compositions comprising said variant(s) or nucleic acid encoding the same and use thereof
08/28/2003WO2003070766A2 A transducer of mas signalling
08/28/2003WO2003070765A2 Growth hormone fusion protein
08/28/2003WO2003070764A1 Method for producing interferon
08/28/2003WO2003070763A1 Methods and compositions for treating metabolic bone diseases relating to human endokine alpha
08/28/2003WO2003070762A1 Compositions isolated from bovine mammary gland and methods for their use
08/28/2003WO2003070761A1 Dual-effect ligands comprising anti-inflammatory hsp peptide epitopes for immunomodulation
08/28/2003WO2003070760A2 Anti-amyloid beta antibodies and their use
08/28/2003WO2003070759A2 Method of modulating e-cadherin mediated cell adhesion
08/28/2003WO2003070758A1 Regulation of human cation transport atpase-like protein
08/28/2003WO2003070757A1 Nucleic acid encoding an herv-h polypeptide for diagnosing colorectal cancer
08/28/2003WO2003070752A2 Mhc-peptide complex binding ligands
08/28/2003WO2003070751A2 Partial peptide mimetics and methods
08/28/2003WO2003070749A2 Self-assembly of peptide-amphiphile nanofibers under physiological conditions
08/28/2003WO2003070748A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
08/28/2003WO2003070747A2 Insulin and igf-1 receptor agonists and antagonists
08/28/2003WO2003070746A2 Purification and characterization of a prothrombin activator from the bristled of lonomia obliqua
08/28/2003WO2003070282A2 Synthesis of lipopolysaccharide-protein conjugate vaccines via the lipid a region following removal of the glycosidic phosphate residue
08/28/2003WO2003070271A2 Novel complexes for inducing an immune response
08/28/2003WO2003070268A1 Remedy for infections
08/28/2003WO2003070267A1 Enhancing the availability of minerals by using biologically active peptides
08/28/2003WO2003070192A2 Compositions and methods for surrogate antibody modulation of an immune response and transport
08/28/2003WO2003070190A2 Surrogate antibodies and methods of preparation and use thereof
08/28/2003WO2003070187A2 Fusion proteins of mycobacterium tuberculosis
08/28/2003WO2003070176A2 Modified defensins and their use
08/28/2003WO2003070164A2 Attenuated mycobacterium tuberculosis vaccines
08/28/2003WO2003069999A1 Proteins for helicobacter diagnosis
08/28/2003WO2003069984A2 Transgenic production in saliva
08/28/2003WO2003069980A2 Precise breeding
08/28/2003WO2003062273A3 Modulator of the notch signalling pathway and use thereof in medical treatment
08/28/2003WO2003060121A3 Compositions and methods relating to gastric specific genes and proteins
08/28/2003WO2003059397A3 Labeling targeting agents with gallium-68 and gallium-67
08/28/2003WO2003055911A3 Cystine-knot fold protein
08/28/2003WO2003053158A3 Malleable protein matrix and uses thereof
08/28/2003WO2003043986A8 Polypeptides of moraxella (branhamella) catarrhalis
08/28/2003WO2003035690A3 Hybrid and fusion polypeptide subunits of k+ channels
08/28/2003WO2003029289A3 Fragements of heat shock proteins and their use
08/28/2003WO2003025015A3 A soluble toll-like receptor
08/28/2003WO2003023009A3 G-protein coupled receptors
08/28/2003WO2003020905A3 Nucleic acid compositions conferring disease resistance
08/28/2003WO2003020894A3 Insulin related transcription factor and uses thereof
08/28/2003WO2003020757A3 Novel genetic products obtained from ashbya gossypii, which are associated with transcription mechanisms, rna processing and/or translation
08/28/2003WO2003018631A3 Nogo receptor homologues and their use
08/28/2003WO2003016522A3 Methods and compounds for the targeting of protein to exosomes
08/28/2003WO2003014153A3 Cellular virus receptors and methods of use.
08/28/2003WO2003008932A3 Size enhanced hemoglobins: surface decoration and crosslinking of the protein with polyoxy akylene glycols
08/28/2003WO2003006659A3 Plant transcriptional repressor, proteic nuclear factors binding thereto, and uses thereof
08/28/2003WO2003005957A3 Mutants of clostridium septicum alpha toxin and vaccines, antibodies, sera, and methods of treatment therewith
08/28/2003WO2003002105A3 Use of tyrosine kinase inhibitors for treating bone loss
08/28/2003WO2002102990A3 Fibroblast growth factor and nucleic acid encoding same
08/28/2003WO2002102850A3 Gene therapy for hemophilia a
08/28/2003WO2002102837A3 Marker for identifying hematopoietic stem cells
08/28/2003WO2002101043A3 Regulation of human ta4 receptor
08/28/2003WO2002101026A3 Methods for binding acma-type protein anchor fusions to cell-wall material of micro-organisms
08/28/2003WO2002099106A3 Regulation of human secretin -type gpcr
08/28/2003WO2002099082A3 Expression of spider silk proteins in higher plants
08/28/2003WO2002097044A3 Alternative splice forms of proteins as basis for multiple therapeutic modalities
08/28/2003WO2002092818A3 Streptococcus agalactiae genome sequence, use for developing vaccines, diagnostic tools, and for identifying therapeutic targets
08/28/2003WO2002092787A3 Human secreted proteins
08/28/2003WO2002090557A3 Freeze-tolerant eukaryotic cells
08/28/2003WO2002086093A9 Methods of using a hyaluronan receptor
08/28/2003WO2002081696A3 Oryza sativa nuclear cap binding protein 80
08/28/2003WO2002081687A3 Yeast genes that affect viral replication
08/28/2003WO2002081521A3 Osteoprotegerin in milk
08/28/2003WO2002081517A3 Novel polypeptides and nucleic acids encoded thereby
08/28/2003WO2002081508A3 Use of cd25 binding molecules in steroid-resistant patients
08/28/2003WO2002078603A3 Plasmodium falciparum erythrocyte binding protein baebl for use as a vaccine
08/28/2003WO2002077021A3 Streptococcus pneumoniae proteins and nucleic acids
08/28/2003WO2002075314A3 Detection and treatment of prostate cancer
08/28/2003WO2002075273A3 Screening, diagnostic and/or dosage method and device of an agonist and/or antagonist for a calcium-coupled receptor
08/28/2003WO2002074905A9 Leptin induced genes
08/28/2003WO2002074797A3 Protein having multiple antigen/epitope sequences and being immobilized for the diagnosis of hiv infections
1 ... 1543 1544 1545 1546 1547 1548 1549 1550 1551 1552 1553 1554 1555 1556 1557 1558 1559 1560 1561 1562 1563 ... 2916